Research Grants Awarded

Reseach grants support Minnesota scientific and medical research that has the potential to translate to clinical advances in regenerative medicine. Grants typically open every September. Learn more about how to apply for a grant by reading our frequently asked questions. 

 

View research grants awarded by year.
image of Shernan Holtan, MD
Shernan G. Holtan, MD
Phase I/II study of human chorionic gonadotropin and epidermal growth factor supplementation (Pregnyl) to support tolerance and repair as adjunct therapy in high-risk or refractory acute graft-versus-host disease
Interim report: Patient enrollment continues. Additionally, correlative studies have provided important data on regulatory T cell responses and…
2017-2019
image of Jop H. van Berlo, MD, PhD
Jop H. van Berlo, MD, PhD
Identification of novel regulators of heart regeneration
Dr. van Berlo’s research aims to help children born with heart disease. He is researching the triggers that can increase cardiac muscle after birth…
2017-2019
image of Michael McAlpine, PhD
Michael C. McAlpine, PhD
4D printed programmable release capsules for spatial control of differentiation in 3D printed cardiac tissue
Using stem cells to repair damaged heart tissue is a promising, but complex area of research. Dr. McAlpine’s research aims to take a significant…
2017-2019
image of Mi-Hyeon Jang, PhD
Mi-Hyeon Jang, PhD
Role of checkpoint kinase in myelin regeneration
Multiple sclerosis and other diseases attack the myelin, a sheath that insulates the nerves. Dr. Jang is investigating the underlying molecular…
2017-2019
image of Karen Echeverri, PhD
Karen Echeverri, PhD
Spinal cord regeneration: translating from salamanders to enhance regenerative repair after injury in mammals
Some salamanders can regenerate a fully functional spinal cord after injury, but humans and other mammals can’t. Dr. Echeverri’s research has…
2017-2019
image of Patricia Devaux, PhD
Patricia Devaux, PhD
Derivation of clinical grade transgene-free human iPSC using a newly developed measles reprogramming system for the treatment of diabetes.
Dr. Devaux is testing a new way of making human blood cells go back to a state from which they can then develop into other kinds of cells,…
2017-2019
image of Sunny Chan, PhD
Sunny Chan, PhD
Generation of second heart field and head muscle progenitors by modeling cardiopharyngeal mesoderm
Some common birth defects affect the muscles of both a child’s face and heart. Dr. Chan is working on a pluripotent stem cell model that produces…
2017-2019
image of Nathan P. Staff, MD, PhD
Nathan P. Staff, MD, PhD
A Phase IIA study using intrathecal treatment of autologous adipose-derived mesenchymal stem cells for amyotrophic lateral sclerosis
The overall objective of this proposal is to conduct a multi-site, placebo-controlled Phase IIA clinical trial to obtain clinical data on the…
2016-2018
image of Ann M. Parr, MD, PhD
Ann M. Parr, MD, PhD
Generating human neural stem and progenitor cells in a porcine model through blastocyst complementation
Porcine blastocyst complementation utilizing human pluripotent stem cells (hPSCs) is a potentially transformative approach that could generate…
2016-2018
image of Kimberly Holst, MD
Kimberly Holst, MD
Phase I study of delivery of autologous bone marrow derived mononuclear cells to myopathic right ventricle in patients with Ebstein anomaly during surgical intervention
The goal of this Phase I study is to establish the safety and feasibility of intramyocardial injection of autologous bone marrow derived…
2016-2018
image of Daniel J. Garry, MD, PhD
Daniel J. Garry, MD, PhD
Humanized vasculature in gene edited animals
The long term goal of our research proposal is to generate a human organ (vasculature) in pigs, which will serve as an unlimited source of vessels…
2016-2018
image of Brian Fife, PhD
Brian Fife, PhD
Identifying and targeting antigen specific T cells in diabetes to preserve beta cells
The primary goals of this project are to restore immune homeostasis that allows islet beta cell survival and regeneration as a cure for Type 1…
2016-2018